Eton Pharmaceuticals (ETON) Other Non-Current Liabilities (2017 - 2026)

Eton Pharmaceuticals has disclosed Other Non-Current Liabilities across 5 years of filings, most recently posting $3.9 million for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities fell 43.34% year-over-year to $3.9 million; the TTM figure through Jun 2026 stood at $3.9 million (down 43.34% YoY), while the FY2025 annual figure was $5.2 million, up 186.39% from the prior year.
• Other Non-Current Liabilities came in at $3.9 million for Q2 2026 at Eton Pharmaceuticals, down from $5.2 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $6.9 million in Q2 2025 to a low of $1.8 million in Q4 2024.
• Average Other Non-Current Liabilities over 3 years is $4.5 million, with a median of $4.7 million recorded in 2025.
• Year-over-year, Other Non-Current Liabilities jumped 186.39% in 2025 and tumbled 43.34% in 2026.
• Over 3 years, Other Non-Current Liabilities stood at $1.8 million in 2024, then jumped by 186.39% to $5.2 million in 2025, then slipped by 24.88% to $3.9 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $3.9 million in Q2 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.